Inicio › Enfermedad de Parkinson › Míchigan
Ensayos clínicos de Enfermedad de Parkinson en Míchigan
22 estudios sobre Enfermedad de Parkinson buscan participantes en Míchigan.
Ciudades en Míchigan
Texto oficial del estudio (inglés)
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-015, Farmington Hills
ReclutandoFase 2/3
Edades de 40 a 80 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06976268Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- University of Michigan, Ann Arbor
- Michigan State University, East Lansing
- Quest Research Institute, Farmington Hills
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07005180A Study of Buntanetap in Participants With PD
- Quest Research Institute, Farmington Hills
ReclutandoFase 2/3
Edades de 40 a 85 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07284784A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #002, Farmington Hills
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- University of Michigan Health System (UMHS) (Site #202), Ann Arbor
- Quest Research Institute - Alcanza - PPDS (Site #201), Farmington Hills
ReclutandoFase 2
Edades de 30 a 80 · Todos los sexos · Actualizado el 10 sept 2026 · NCT07432958A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
- Quest Research Institute - Alcanza - HyperCore - PPDS, Farmington Hills
ReclutandoFase 2
Edades de 40 a 85 · Todos los sexos · Actualizado el 8 sept 2026 · NCT07514858A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- University of Michigan, Ann Arbor
ReclutandoEstudio observacional
Edades de 45 a 75 · Todos los sexos · Actualizado el 4 sept 2026 · NCT07330258A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Quest Research Institute, Farmington Hills
ReclutandoFase 3
Edades de 50 a 85 · Todos los sexos · Actualizado el 3 sept 2026 · NCT07174310A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease
- Quest Research Institute - Alcanza, Farmington Hills
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 30 a 80 · Todos los sexos · Actualizado el 1 sept 2026 · NCT06565195A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Quest Research Institute, Farmington Hills
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 28 ago 2026 · NCT06680830A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
- Domino's Farms, Ann Arbor
ReclutandoFase 1
Edades de 50 en adelante · Todos los sexos · Actualizado el 14 ago 2026 · NCT07543861A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Michigan Clinical Research Unit - Neurology, Ann Arbor
- University of Michigan Clinical Research Unit - Neurology, Ann Arbor
- Quest Research Institute, Farmington Hills
ReclutandoFase 3
Edades de 45 a 75 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06944522PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- University of Michigan, Ann Arbor
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 30 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT04477785A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- Michigan State University (Neurology), East Lansing
- Quest Research Institute (Neurology), Farmington Hills
ReclutandoFase 2
Edades de 45 a 75 · Todos los sexos · Actualizado el 29 jun 2026 · NCT06285643Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation
- University of Michigan, Ann Arbor
ReclutandoEstudio observacional
Edades de 45 en adelante · Todos los sexos · Actualizado el 11 jun 2026 · NCT07642908Natural History Study of Synucleinopathies
- University of Michigan, Ann Arbor
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 jun 2026 · NCT01799915SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- Quest Research Institute, Farmington Hills
ReclutandoFase 1
Edades de 40 a 80 · Todos los sexos · Actualizado el 5 jun 2026 · NCT07422675Speech Amplification Devices for Parkinson Disease: Talker- and Technology-Driven Enhancements
- Michigan State University, East Lansing
Reclutando
Edades de 50 en adelante · Todos los sexos · Actualizado el 20 may 2026 · NCT07599696A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease
- QUEST Research Institute, Farmington Hills
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 30 a 85 · Todos los sexos · Actualizado el 20 abr 2026 · NCT06809400Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease
- University of Michigan, Ann Arbor
ReclutandoFase 2
Edades de 45 en adelante · Todos los sexos · Actualizado el 31 mar 2026 · NCT06679374Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
- Domino's Farms, Ann Arbor
ReclutandoFase 1/2
Edades de 45 en adelante · Todos los sexos · Actualizado el 12 nov 2025 · NCT07154511A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Quest Research Institute, Farmington Hills
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2025 · NCT06765668De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.